TransMed7 LLC (TransMed7) is a medical technology company that develops and manufactures biopsy devices. The company provides handheld soft tissue biopsy, stereotactic soft tissue biopsy, fine needle biopsy, vascular intervention, excisional soft tissue biopsy, prostate soft tissue biopsy, endoscopic soft tissue biopsy, robotic soft tissue biopsy, bone marrow biopsy, and laparoscopic biopsy. Its stereotactic soft tissue biopsy is used in the field of breast health. The company’s fine needle biopsy is used in lymph node, thyroid, liver, pancreas, and kidney biopsy applications. TransMed7 is headquartered in Phoenix, Arizona, the US
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TransMed7 LLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- TransMed7 LLC Company Overview
- TransMed7 LLC Company Snapshot
- TransMed7 LLC Pipeline Products and Ongoing Clinical Trials Overview
- TransMed7 LLC - Pipeline Analysis Overview
- TransMed7 LLC - Key Facts
- TransMed7 LLC - Major Products and Services
- TransMed7 LLC Pipeline Products by Development Stage
- TransMed7 LLC Pipeline Products Overview
- Corsair Atherectomy Device
- Corsair Atherectomy Device Product Overview
- Corsair II
- Corsair II Product Overview
- Cygnet Interventional Device
- Cygnet Interventional Device Product Overview
- Heron - 16G
- Heron - 16G Product Overview
- Heron - 18G
- Heron - 18G Product Overview
- Heron XPS
- Heron XPS Product Overview
- Hurricane
- Hurricane Product Overview
- Martinet Soft Tissue Excisional Biopsy Device
- Martinet Soft Tissue Excisional Biopsy Device Product Overview
- Mustang
- Mustang Product Overview
- Next-Gen Cardinal Fine-Needle Core Biopsy Device
- Next-Gen Cardinal Fine-Needle Core Biopsy Device Product Overview
- Osprey
- Osprey Product Overview
- Phoenix Endoscopic Biopsy Device
- Phoenix Endoscopic Biopsy Device Product Overview
- Thunderbird
- Thunderbird Product Overview
- Warhawk
- Warhawk Product Overview
- Zeppelin II
- Zeppelin II Product Overview
- TransMed7 LLC - Key Competitors
- TransMed7 LLC - Key Employees
- TransMed7 LLC - Locations And Subsidiaries
- Head Office
- Recent Developments
- TransMed7 LLC, Recent Developments
- Sep 06, 2023: TransMed7 Announces First Revenue from Concorde Family of Devices
- Mar 21, 2023: TransMed announces first clinical use of VacuPac, a new self-contained, vacuum-assist attachment for all of its vacuum-assisted, Single Insertion - Multiple Collection (SIMC) platforms of biopsy devices
- Feb 06, 2023: TransMed7 announces first clinical cases of Concorde Soft Tissue Biopsy Devices for Commercial Launch
- Aug 16, 2022: TransMed7 announces first clinical use of Heron soft tissue biopsy devices for commercial launch
- Aug 09, 2022: TransMed7 announces first clinical use of SpeedBird breast biopsy devices for commercial launch
- Sep 22, 2020: TransMed7 announces first results from clinical use of its vacuum-assisted, Single Insertion - Multiple Collection (SIMC) platform of breast biopsy devices
- Sep 01, 2020: TransMed7 announces 510(k) clearance by the U.S. FDA for its Concorde US (Ultrasound) and Concorde ST (Stereotactic) Soft Tissue Biopsy Device Platform
- Sep 18, 2018: TransMed7 announces the availability of Concorde, the stereotactic table variant of its SpeedBird Biopsy device platform
- Jun 20, 2018: TransMed7 Announces 510(k) Clearance by the U.S. FDA for its SpeedBird Soft Tissue Biopsy Device Platform
- Nov 07, 2017: TransMed7 receives U.S. Patent No. 9,808,226 for SpeedBird soft tissue biopsy platform technology
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- TransMed7 LLC Pipeline Products and Ongoing Clinical Trials Overview
- TransMed7 LLC Pipeline Products by Equipment Type
- TransMed7 LLC Pipeline Products by Indication
- TransMed7 LLC, Key Facts
- TransMed7 LLC, Major Products and Services
- TransMed7 LLC Number of Pipeline Products by Development Stage
- TransMed7 LLC Pipeline Products Summary by Development Stage
- Corsair Atherectomy Device - Product Status
- Corsair Atherectomy Device - Product Description
- Corsair II - Product Status
- Corsair II - Product Description
- Cygnet Interventional Device - Product Status
- Cygnet Interventional Device - Product Description
- Heron - 16G - Product Status
- Heron - 16G - Product Description
- Heron - 18G - Product Status
- Heron - 18G - Product Description
- Heron XPS - Product Status
- Heron XPS - Product Description
- Hurricane - Product Status
- Hurricane - Product Description
- Martinet Soft Tissue Excisional Biopsy Device - Product Status
- Martinet Soft Tissue Excisional Biopsy Device - Product Description
- Mustang - Product Status
- Mustang - Product Description
- Next-Gen Cardinal Fine-Needle Core Biopsy Device - Product Status
- Next-Gen Cardinal Fine-Needle Core Biopsy Device - Product Description
- Osprey - Product Status
- Osprey - Product Description
- Phoenix Endoscopic Biopsy Device - Product Status
- Phoenix Endoscopic Biopsy Device - Product Description
- Thunderbird - Product Status
- Thunderbird - Product Description
- Warhawk - Product Status
- Warhawk - Product Description
- Zeppelin II - Product Status
- Zeppelin II - Product Description
- TransMed7 LLC, Key Employees
- Glossary
- TransMed7 LLC Pipeline Products by Equipment Type
- TransMed7 LLC Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biopsy Sciences, LLC
- 3DBiopsy Inc
- Biopsys Medical Inc
- Multiple Biopsy System
- Laser Biopsy, Inc.
